Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease

Background: Graves’ disease (GD) is a common autoimmune disease, and its pathogenesis is unclear. Studies have found that the occurrence of GD is related to the immune disorder caused by the interaction of genetic susceptibility and environmental factors. The CD4+ T cell subset is closely related to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qiuming Yao, Zhenyu Song, Bin Wang, Xi Jia, Ronghua Song, Jinan Zhang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/5086f6a98a524125ba534780068aaae2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5086f6a98a524125ba534780068aaae2
record_format dspace
spelling oai:doaj.org-article:5086f6a98a524125ba534780068aaae22021-12-02T01:34:40ZIdentification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease2296-634X10.3389/fcell.2021.756560https://doaj.org/article/5086f6a98a524125ba534780068aaae22021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcell.2021.756560/fullhttps://doaj.org/toc/2296-634XBackground: Graves’ disease (GD) is a common autoimmune disease, and its pathogenesis is unclear. Studies have found that the occurrence of GD is related to the immune disorder caused by the interaction of genetic susceptibility and environmental factors. The CD4+ T cell subset is closely related to the immune disorder of GD. LncRNAs are RNA molecules with a length of more than 200 nt and are involved in a variety of autoimmune diseases. However, the roles of lncRNAs in recurrent GD are still elusive. The purpose of this study is to identify lncRNA and mRNA expression profile in relapsed Graves’ disease.Method: CD4+ T cells from 12 recurrent GD and 8 healthy controls were collected for high-throughput sequencing. The gene-weighted co-expression network analysis (WGCNA) was used to construct the co-expression module relevant to recurrent GD, and the key genes in the module were verified by RT-PCR.Results: There are 602 upregulated lncRNAs and 734 downregulated lncRNAs in CD4+ T cells in recurrent GD patients compared with the healthy controls. The module most relevant to GD recurrence was constructed using WGCNA, and the key genes in the module were verified by RT-PCR. We found that the expression of RPL8, OAS2, NFAT5, DROSHA, NONHSAT093153.2, NONHSAT118924.2, and NONHSAT209004.1 was significantly decreased in GD group (p < 0.001, p < 0.001, p < 0.01, p < 0.05, p < 0.001, p < 0.05, and p < 0.01, respectively).Conclusion: LncRNAs are closely related to the recurrence of GD. For the first time, we constructed the expression profile of lncRNAs and mRNAs in CD4+ T cells in recurrent GD patients.Qiuming YaoZhenyu SongBin WangXi JiaRonghua SongJinan ZhangFrontiers Media S.A.articlelncRNAsrelapsed GDWGCNANONHSAT093153.2NONHSAT209004.1Biology (General)QH301-705.5ENFrontiers in Cell and Developmental Biology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic lncRNAs
relapsed GD
WGCNA
NONHSAT093153.2
NONHSAT209004.1
Biology (General)
QH301-705.5
spellingShingle lncRNAs
relapsed GD
WGCNA
NONHSAT093153.2
NONHSAT209004.1
Biology (General)
QH301-705.5
Qiuming Yao
Zhenyu Song
Bin Wang
Xi Jia
Ronghua Song
Jinan Zhang
Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease
description Background: Graves’ disease (GD) is a common autoimmune disease, and its pathogenesis is unclear. Studies have found that the occurrence of GD is related to the immune disorder caused by the interaction of genetic susceptibility and environmental factors. The CD4+ T cell subset is closely related to the immune disorder of GD. LncRNAs are RNA molecules with a length of more than 200 nt and are involved in a variety of autoimmune diseases. However, the roles of lncRNAs in recurrent GD are still elusive. The purpose of this study is to identify lncRNA and mRNA expression profile in relapsed Graves’ disease.Method: CD4+ T cells from 12 recurrent GD and 8 healthy controls were collected for high-throughput sequencing. The gene-weighted co-expression network analysis (WGCNA) was used to construct the co-expression module relevant to recurrent GD, and the key genes in the module were verified by RT-PCR.Results: There are 602 upregulated lncRNAs and 734 downregulated lncRNAs in CD4+ T cells in recurrent GD patients compared with the healthy controls. The module most relevant to GD recurrence was constructed using WGCNA, and the key genes in the module were verified by RT-PCR. We found that the expression of RPL8, OAS2, NFAT5, DROSHA, NONHSAT093153.2, NONHSAT118924.2, and NONHSAT209004.1 was significantly decreased in GD group (p < 0.001, p < 0.001, p < 0.01, p < 0.05, p < 0.001, p < 0.05, and p < 0.01, respectively).Conclusion: LncRNAs are closely related to the recurrence of GD. For the first time, we constructed the expression profile of lncRNAs and mRNAs in CD4+ T cells in recurrent GD patients.
format article
author Qiuming Yao
Zhenyu Song
Bin Wang
Xi Jia
Ronghua Song
Jinan Zhang
author_facet Qiuming Yao
Zhenyu Song
Bin Wang
Xi Jia
Ronghua Song
Jinan Zhang
author_sort Qiuming Yao
title Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease
title_short Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease
title_full Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease
title_fullStr Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease
title_full_unstemmed Identification of lncRNA and mRNA Expression Profile in Relapsed Graves’ Disease
title_sort identification of lncrna and mrna expression profile in relapsed graves’ disease
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5086f6a98a524125ba534780068aaae2
work_keys_str_mv AT qiumingyao identificationoflncrnaandmrnaexpressionprofileinrelapsedgravesdisease
AT zhenyusong identificationoflncrnaandmrnaexpressionprofileinrelapsedgravesdisease
AT binwang identificationoflncrnaandmrnaexpressionprofileinrelapsedgravesdisease
AT xijia identificationoflncrnaandmrnaexpressionprofileinrelapsedgravesdisease
AT ronghuasong identificationoflncrnaandmrnaexpressionprofileinrelapsedgravesdisease
AT jinanzhang identificationoflncrnaandmrnaexpressionprofileinrelapsedgravesdisease
_version_ 1718402956731088896